Lactobacillus Probiotics for Pediatric Use

Condition-Specific Dosing

For acute gastroenteritis, the American Academy of Pediatrics recommends L. rhamnosus ATCC 53103 at 1 × 10¹⁰ CFU twice daily for 5 days, although recent high-quality North American trials showed no significant benefit 1
A two-strain combination (L. rhamnosus R0011 + L. helveticus R0052) at 4 × 10⁹ CFU twice daily for 5 days may be effective for acute gastroenteritis 1
The American Academy of Pediatrics suggests a duration of 5-7 days for acute episodes of gastroenteritis 2

For extremely low birth weight premature infants (<1,000g, <28 weeks), the American Academy of Pediatrics recommends L. reuteri DSM 17938 at 1.25 × 10⁸ CFU daily from birth to 36 weeks postmenstrual age, which has shown benefits for head growth and weight gain 3, 4, 5
For the general preterm population, a multi-strain formulation (Infloran) at 1 × 10⁹ CFU each of L. acidophilus and B. bifidum daily may be effective 6

The American Academy of Pediatrics states that immunocompromised children have an absolute contraindication for probiotics due to bacteremia risk 2
The American Gastroenterological Association explicitly advises against probiotics for children with Crohn's disease based on very low-quality evidence showing no benefit 2

The World Gastroenterology Organisation notes that efficacy is strain-specific, with different Lactobacillus strains showing varying effectiveness even at similar doses 1
L. reuteri DSM 17938 at 1-1.25 × 10⁸ CFU has shown more persistent colonization than other strains 6

The American Academy of Pediatrics recommends capsules or sachets as the standard formulation for ambulatory children, and liquid formulations for children with swallowing difficulties 2
Clinicians must verify that products contain viable (live) bacteria at the specified CFU counts, as there is wide variation in product quality, according to the National Institutes of Health 7